RedHill Biopharma reported $1000K in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Cara Therapeutics USD 366M 338M Sep/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
Cronos Group USD 1B 55.93M Dec/2025
RedHill Biopharma USD 12M 17M Jun/2024